U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07430956) titled 'Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable' on Feb. 18.
Brief Summary: This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. When this happens, blood cannot move smoothly through the heart; it can slow down or pool in one spot, which can lead to the formation of blood clots.
REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillati...